Dermatoscopy Doctors Abroad — Page 2

Dr. Joan Ramon Garces Gatnau is a leading specialist in oncodermatology. He performs skin cancer screening and complex dermatoscopy at Centro Médico Teknon.

• Directs the Mohs Unit at the Autonomous University of Barcelona
• Performed 1,400 to 2,000 Mohs micrographic surgeries throughout his career
• Clinical Head of Dermatology at Hospital de Sant Pau in Barcelona
• Member of the International Society for Dermatologic Surgery (ISDS)
• Authored specialized research on eyebrow and lip reconstruction after tumor removal

Dr. Alejandro Camps is a dermatologist at Teknon Medical Center in Barcelona. He is a founder of the European Society of Mohs Micrographic Surgery. Dr. Camps specializes in skin cancer treatment and hair transplantation. He has practiced medical and surgical dermatology for several decades.

• Performs Mohs micrographic surgery for highly precise skin cancer removal.
• Expert in laser removal of vascular lesions, tattoos, and pigmented spots.
• Former President of the International Society of Dermatologic Surgery.
• Founder and Vice President of the Spanish Society of Hair Transplantology.

Dr. Christiane Thallinger is a specialist in skin cancer and oncologic dermatology at Wiener Privatklinik. She is a recognized expert in treating melanoma and basal cell carcinoma in Austria. Dr. Thallinger focuses on managing skin complications caused by cancer therapies. She previously served as a senior physician at the Medical University of Vienna.

• Performs digital mole mapping and dermoscopy for early skin cancer detection.
• Treats complex skin reactions induced by chemotherapy and immunotherapy.
• Performs surgical tumor excision, cryotherapy, and photodynamic therapy.
• Conducts research on immune-related skin toxicities to improve patient outcomes.

Dr. López Gil Francisco José is the Medical Director of the Dermatology Department at Centro Médico Teknon. He specializes in clinical, aesthetic, and oncological dermatology. Dr. López Gil focuses on skin cancer prevention and laser therapy. He leads a multidisciplinary team to treat hair loss and hyperhidrosis.

• Founded the dermatology department at the JCI-accredited Teknon Medical Center.
• Expert in dermatological surgery and surgical venereology.
• Performs ARTAS robotic hair transplants and stem cell rejuvenation.
• Established the DermAndTek clinic in Andorra for comprehensive skin care.

Dr. Tamara Kopp is a consultant dermatologist at Wiener Privatklinik in Vienna. She combines clinical precision with aesthetic dermatology for personalized skin health. Dr. Kopp previously held a senior role at a leading dermatology clinic. She completed her specialist training at the Vienna General Hospital.

• Performs digital mole mapping and skin cancer screening with dermoscopy.
• Treats clinical conditions such as psoriasis, neurodermatitis, and alopecia.
• Provides aesthetic treatments including laser therapy, fillers, and Botox.
• Practices at Wiener Privatklinik, ranked among the World's Best Hospitals by Newsweek.

Dr. Tahsin Ozadli is a medical oncologist at Valued Med Hub Hospitals in Istanbul. He specializes in the treatment of lung, breast, and gastrointestinal cancers. Dr. Ozadli holds a specialization from the Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital. He works at a center authorized by the Turkish government for international health tourism.

• Administers immunotherapy, targeted therapy, and chemotherapy for multiple cancer types.
• Treats complex conditions including sarcoma, medulloblastoma, and nasopharyngeal cancer.
• Performs diagnostic procedures including liver biopsies, thyroid biopsies, and cancer screenings.
• Utilizes PET/CT and MRI for precise abdominal and pelvic tumor tracking.

Dr. Emel Erunal is a dermatologist and dermatologic surgeon at Medical Park Antalya Hospital Complex. She specializes in aesthetic medicine and hair restoration. Dr. Erunal performs robotic hair transplants and stem cell rejuvenation therapies. She holds memberships in the Aesthetic and Cosmetic Dermatology Society and the Turkish Dermatology Society.

• Performs ARTAS robotic hair transplants and moustache transplantation.
• Provides exosome therapy and rejuvenation using donor or autologous stem cells.
• Treats acne and scarring using laser resurfacing and COOL PEEL techniques.
• Performs non-surgical facial contouring, including jaw fillers and thread lifting.

Dr. Baha Zengel is a general surgeon at Medicalpoint International Hospital. He specializes in oncoplastic breast surgery and thyroid diseases. He holds a doctorate in Basic Oncology from Dokuz Eylül University. Dr. Zengel serves as a founding board member of the Basic Oncology Association. He works at a JCI-accredited facility in İzmir.

• Performs breast-conserving mastectomy and simultaneous reconstructions.
• Expert in ROLL and SNOLL localization techniques for non-palpable lesions.
• Treats patients using laparoscopic cholecystectomy for gallbladder diseases.
• Former board member of the Aegean Region Surgery Association.

Dr. Erkan Davarci is a dermatology specialist at Medical Park Antalya. He uses dermatoscopy to evaluate moles and skin lesions accurately.

• Trained at Ankara University Faculty of Medicine – a premier medical school
• Completed dermatology residency at the Ankara Training and Research Hospital
• Focuses on identifying skin lesions and performing mole removal
• Member of the Turkish Dermatology Society for professional standards
• Active in the Aesthetic and Cosmetic Dermatology Society for skin care

Professor Hwang Sung-joo is Director of the Hair Transplant Center at Myongji Hospital. He is an internationally recognized hair restoration surgeon with more than 30 years of experience. He performs FUT, FUE, and complex repair procedures. He has transplanted about 50 million hairs.

He was the first Korean President of the ISHRS. He founded and led the Asian and Korean hair restoration surgery societies. He received the ISHRS Platinum Follicle Award. He developed DCT (Depth Controlled Transplantation) and an implantation device to improve graft survival. He performed Korea’s first sister-to-sister hair transplant after bone marrow transplantation in 2005, and a mother-to-daughter transplant in 2025. He wrote a Korean textbook and co-wrote U.S. and Asian texts.

Dr. Hasan Mutlu is a medical oncologist at Medical Park Antalya Hospital Complex. He specializes in immunotherapy, targeted cancer therapies, and genetic research in cancer treatment. Dr. Mutlu received his medical degree from Hacettepe University. He holds the title of Professor of Medicine. Dr. Mutlu focuses on organ tumor diagnosis and chemotherapy.

• Specializes in both medical and pediatric oncology cases.
• Treats complex conditions including neuroblastoma, Wilms tumor, and Ewing's sarcoma.
• Performs biological therapies and stays active in next-generation genetic research.
• Works at the Mediterranean region’s largest private hospital with PET-CT and LINAC technology.

Dr. Ayse Callioglu is a skin specialist at Medical Park Antalya. She performs dermatoscopy to check moles and skin health across Turkey's Mediterranean coast.

• Member of the European Academy of Dermatology and Venereology (EADV)
• Trained at Ege University and Akdeniz University medical faculties
• Active member of the Turkish Society of Dermatology
• Member of the Mediterranean Society of Dermatology
• Registered with the International Society of Cosmetic Dermatology

Dr. Mustafa Serkan Alemdar is a clinical oncologist at Medical Park Antalya Hospital Complex. He specializes in treating complex solid tumors and blood cancers. Dr. Alemdar completed his medical degree and oncology fellowship at Akdeniz University. He is an active member of the Turkish Society of Medical Oncology.

• Treats a wide range of cancers including breast, lung, and prostate.
• Expert in hematology-oncology for conditions like leukemia, myeloma, and lymphoma.
• Performs systemic therapies such as chemotherapy, immunotherapy, and targeted biological therapy.
• Works at a facility that houses specialized oncology-bone marrow units and LINAC technology.

Dr. Ayse Akkus is a dermatologist at VM Medical Park Pendik Hospital in Istanbul. She specializes in skin treatments and medical aesthetics. Dr. Akkus is a member of the Turkish Dermatology Association. She has published research in international peer-reviewed journals on nail and skin conditions. Her work is featured in professional publications like Dermatologic Therapy.

• Performs chemical matricectomy, laser mole removal, and scar revision.
• Treats dermatological conditions using stem cell rejuvenation and phototherapy.
• Provides Botox injections, fillers, and mesotherapy for facial rejuvenation.
• Practices at JCI-accredited VM Medical Park Pendik Hospital.

Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.

1980–1985: Completed doctoral studies at Nagasaki University, Japan

1968–present: Department of Radiology, Chinese PLA General Hospital

1988: Third Prize of the Military Science and Technology Progress Award

1989–present: Member of Radiological Society of North America(RSNA)

1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA

1991: Second Prize of the Military Science and Technology Progress Award

1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology

1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

1993: Granted the Lifetime Special Government Allowance of the State Council

1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology

1994: Third Prize of the Military Science and Technology Progress Award

1997: Second Prize of the Military Science and Technology Progress Award

1997–2009: Standing Member of Chinese Society of Radiology

1999: Third Prize of the Military Science and Technology Progress Award

1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology

2002: Second Prize of the Military Science and Technology Progress Award

2005: Third Prize of the Military Science and Technology Progress Award

Member of Radiological Society of North America(RSNA)

Standing Member of Chinese Society of Radiology

Group Leader of the Group of Intervention of Chinese Journal of Radiology

Deputy Director Member of Chinese Society of Interventional Oncology

Director Member of Beijing Medical Association Society of Interventional Radiology

Deputy Chief Editor of Chinese Journal of Medical Image Technology

Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army

Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

Awarded the Special Government Allowance of the State Council

Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.

Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”

Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.

In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.

Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.

In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.

Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.

From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.

Professor Zhang Jinshan’s Academic Achievements

Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.

Selected Publications by Professor Zhang Jinshan

1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993，27（6）：361-365.

Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.

2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996，30（8）：521-524.

Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.

3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998，14（3）：189-191.

Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.

4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000，34（5）：335-337.

Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.

5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002，36（7）：612-614.

Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.

6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004，20（9）：1395-1397.

Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.

7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006，40（8）：876-878.

Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.

8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.

Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.

Professor Zhang Jinshan co-authored monographs

1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.

2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.

3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.

Professor Zhang Jinshan’s Research project

1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.

2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.

3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.

4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.

Dr. Aleksandra Starosciak graduated from the Medical Academy in Warsaw. She has been a specialist in general surgery since 2009. She is training in surgical oncology. Since 2010, she has worked in the Department of Oncological Surgery at the Holy Family Hospital in Warsaw. She is a member of the Polish Society of Surgical Oncology. She attends scientific and training conferences in general surgery, oncology, plastic surgery, and breast ultrasound.

She performs breast surgery, including tumor removal, reconstruction, and mastectomy. She also performs soft‑tissue and minor procedures, such as removal of skin lesions and nodules. She performs endocrine surgery for malignant and benign thyroid lesions.

She diagnoses breast diseases. She performs ultrasound‑guided vacuum‑assisted (mammotome) breast biopsies. She also performs core needle and fine‑needle aspiration biopsies. She carries out thyroid biopsies and videodermoscopy of skin lesions.

Professor Reuven Bergman is a leading oncodermatologist at Rambam Medical Center. He specializes in identifying skin cancer through dermatoscopy.

• Heads the Department of Dermatology at Rambam Medical Center
• Focuses on oncodermatology – the specialized study and treatment of skin cancers
• Holds a professorship in dermatology at a major medical faculty
• Expert in identifying suspicious moles and early-stage skin lesions

The doctor is a highly skilled specialist in both adult and pediatric ENT diseases, offering comprehensive care for a wide range of ear, nose, and throat conditions. Clinical expertise includes advanced endoscopic and microscopic middle ear surgeries, as well as specialized procedures for sleep apnea and snoring.

In addition to functional ENT treatments, the doctor performs various plastic surgery procedures, including rhinoplasty and protruding ear correction. The practice also incorporates aesthetic medicine, providing professional filling and Botox treatments. Furthermore, the doctor utilizes the modern plasma-evaporation method for tonsil and adenoid operations, ensuring precise and effective surgical outcomes for patients.